Therapy-related core binding factor acute myeloid leukemia

Therapy-related acute myeloid leukemia (t-AML) usually stems from exposure of the bone marrow to cytotoxic chemotherapy and/or radiation therapy. t-AML is usually associated with poor overall survival, but occasionally t-AML can involve favorable-risk cytogenetics, including core binding factor AML...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Binsah, Yohannan, Binoy, Mohlere, Virginia, Gonzalez, Anneliese
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979104/
https://www.ncbi.nlm.nih.gov/pubmed/36874378
http://dx.doi.org/10.2217/ijh-2022-0004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979104/
https://www.ncbi.nlm.nih.gov/pubmed/36874378
http://dx.doi.org/10.2217/ijh-2022-0004

Ejemplares similares